trending Market Intelligence /marketintelligence/en/news-insights/trending/UXJgAZBkA2f05TOVNfLmSA2 content esgSubNav
In This List

Acasti Pharma falls out of compliance with Nasdaq listing requirement

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Acasti Pharma falls out of compliance with Nasdaq listing requirement

Canada's Acasti Pharma Inc. said it was no longer in compliance with Nasdaq's $1 minimum bid price listing requirement.

The drugmaker has until June 24, with a possibly of extension, to regain compliance.

The development has no immediate effect on Acasti's listing. The company said it will evaluate all available options to resolve the deficiency.